Application of Enrofloxacin and Orbifloxacin Disks Approved in Japan for Susceptibility Testing of Representative Veterinary Respiratory Pathogens

In this study, susceptibilities of Pasteurella multocida, Mannheimia haemolytica and Actinobacillus pleuropneumoniae to enrofioxacin and orbifloxacin were tested using an agar diffusion method with the commercial disks and a broth microdilution method. Good correlation between the 2 methods for enrofloxacin and orbifloxacin was observed for P. multocida (r = -0.743 and -0.818, respectively), M haemolytica (r= -0.739 and -0.800, respectively) and A. pleuropneumoniae (r = -0.785 and -0.809, respectively). Based on the Clinical and Laboratory Standards Institute interpretive criteria for enrofioxacin, high-level categorical agreement between the 2 methods was found for P multocida (97.9%), M haemolytica (93.8%) and A. pleuropneumoniae (92.0%). Our findings indicate that the tested commercial disks can be applied for susceptibility testing of veterinary respiratory pathogens.